Search
for
Sort by
Research 811–840 of 1000+
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study
- Collagen/Chitosan Gels Cross-Linked with Genipin for Wound Healing in Mice with Induced Diabetes
- Alopecia Areata: An Autoimmune Disease of Multiple Players
- “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Predictive Metagenomic Profiling, Urine Metabolomics, and Human Marker Gene Expression as an Integrated Approach to Study Alopecia Areata
- Alopecia Areata: An Update on Treatment Options for Children
- Prevalence of alopecia areata in Japan: Estimates from a nationally representative sample
- Increased Circulating CXCL10 in Non-Segmental Vitiligo Concomitant with Autoimmune Thyroid Disease and Alopecia Areata
- Psychosocial and mental impact of alopecia areata: Analysis of the Danish Skin Cohort
- Psychosocial impact of alopecia areata in paediatric and adolescent populations: A systematic review
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Vitamin D and alopecia areata: possible roles in pathogenesis and potential implications for therapy.
- Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata
- Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
- Epidemiological Trends in Alopecia Areata at the Global, Regional, and National Levels
- Association between alopecia areata and COVID-19: A systematic review
- Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan
- Ensemble of pre-learned deep learning model and an optimized LSTM for Alopecia Areata classification
- Baricitinib for the Treatment of Alopecia Areata
- Alopecia Areata Is Associated with Posttraumatic Stress Disorder and Alcohol Use in a Case-Control Study of 4,785 Patients
- Association Between Serum Trace Elements Level and Alopecia Areata: A Systematic Review and Meta‐Analysis
- RETRACTED: Interleukin‐33 links asthma to alopecia areata: Mendelian randomization and mediation analysis
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata
- Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study
- Treatment options for alopecia areata